학술논문
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
Document Type
Article
Author
Leypoldt, L.B.; Bokemeyer, C.; Weisel, K.C.; Tichy, D.; Požek, E.; Benner, A.; Besemer, B.; Hänel, M.; Raab, M.S.; Mann, C.; Munder, M.; Reinhardt, H.C.; Nogai, A.; Görner, M.; Ko, Y.-D.; De Wit, M.; Salwender, H.; Scheid, C.; Graeven, U.; Peceny, R.; Staib, P.; Dieing, A.; Einsele, H.; Jauch, A.; Hundemer, M.; Zago, M.; Goldschmidt, H.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 1 January 2024, 42(1):26-37)
Subject
Language
English
ISSN
15277755
0732183X
0732183X